Report of Foreign Issuer (6-k)
April 26 2016 - 9:30AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 6-K
Report of Foreign Private Issuer Pursuant
to Rule 13a-16 or 15d-16
Under the Securities Exchange Act of 1934
For the Month of April 2016
Commission File No.: 001-33514
TRANSITION
THERAPEUTICS INC.
101 College Street, Suite 220, Toronto, Ontario,
Canada M5G 1L7
(Address of Principal Executive Office)
Indicate by check mark whether the registrant files or will file
annual reports under cover of Form 20-F or Form 40-F. Form 20-F
☒
Form
40-F
☐
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1): Yes
☐
No
☒
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7): Yes
☐
No
☒
The following information is furnished herewith and is incorporated by reference into the following Registration
Statements:
Registration Statement on Form S-8 No. 333-157279
Registration Statement on Form F-3 No. 333-189879
EXHIBITS
The following information is furnished to the SEC as part of this
report on Form 6-K:
Exhibit No.
|
Document
|
|
|
99.1
|
Press Release dated April 25, 2016 - Transition Therapeutics Announces Dosing of First Patient in Phase 2 Study of Drug Candidate TT701
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
TRANSITION THERAPEUTICS INC.
|
|
|
|
|
|
|
Date:
|
April 25, 2016
|
By:
|
/s/ Nicole Rusaw
|
|
|
|
Name:
|
Nicole Rusaw
|
|
|
|
Title:
|
Chief Financial Officer
|
|
Transition Therapeutics - Ordinary Shares (NASDAQ:TTHI)
Historical Stock Chart
From May 2024 to Jun 2024
Transition Therapeutics - Ordinary Shares (NASDAQ:TTHI)
Historical Stock Chart
From Jun 2023 to Jun 2024